{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:53:32Z","timestamp":1768017212609,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR002001"],"award-info":[{"award-number":["UL1 TR002001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ijcard.2020.04.055","type":"journal-article","created":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T02:29:50Z","timestamp":1587263390000},"page":"83-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Long-term milrinone therapy as a bridge to heart transplantation: Safety, efficacy, and predictors of failure"],"prefix":"10.1016","volume":"313","author":[{"given":"Elizabeth C.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"McNitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Martens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey T.","family":"Bruckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leway","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Alexis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Storozynsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabu","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Gosev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Barrus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himabindu","family":"Vidula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijcard.2020.04.055_bb0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1191\/0267659106pf851oa","article-title":"Cardiac organ donor management","volume":"21","author":"Ullah","year":"2006","journal-title":"Perfusion"},{"issue":"6\u20137","key":"10.1016\/j.ijcard.2020.04.055_bb0010","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ejheart.2007.04.003","article-title":"Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology","volume":"9","author":"Metra","year":"2007","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.04.055_bb0015","unstructured":"Organ Procurement and Transplant Network. U.S. Department of Health and Human Services."},{"issue":"1 Pt 1","key":"10.1016\/j.ijcard.2020.04.055_bb0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-8703(99)70250-4","article-title":"Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)","volume":"138","author":"O\u2019Connor","year":"1999","journal-title":"Am. Heart J."},{"issue":"21","key":"10.1016\/j.ijcard.2020.04.055_bb0025","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group","volume":"325","author":"Packer","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2020.04.055_bb0030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1054\/jcaf.2003.24","article-title":"Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure","volume":"9","author":"Hershberger","year":"2003","journal-title":"J. Card. Fail."},{"issue":"6","key":"10.1016\/j.ijcard.2020.04.055_bb0035","doi-asserted-by":"crossref","first-page":"1096.e1","DOI":"10.1016\/j.ahj.2006.08.003","article-title":"Chronic inotropic therapy in end-stage heart failure","volume":"152","author":"Hauptman","year":"2006","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2020.04.055_bb0040","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/CIRCHEARTFAILURE.108.839076","article-title":"Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure","volume":"2","author":"Gorodeski","year":"2009","journal-title":"Circ. Heart Fail."},{"issue":"6","key":"10.1016\/j.ijcard.2020.04.055_bb0045","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.amjcard.2015.12.030","article-title":"Infections, arrhythmias, and hospitalizations on home intravenous inotropic therapy","volume":"117","author":"Acharya","year":"2016","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2020.04.055_bb0050","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ejhf.991","article-title":"Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term Registry","volume":"20","author":"Mebazaa","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"9","key":"10.1016\/j.ijcard.2020.04.055_bb0055","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.healun.2003.08.017","article-title":"A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home","volume":"23","author":"Brozena","year":"2004","journal-title":"J. Heart Lung Transplant."},{"issue":"10","key":"10.1016\/j.ijcard.2020.04.055_bb0060","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cardfail.2008.08.004","article-title":"The use of continuous milrinone therapy as bridge to transplant is safe in patients with short waiting times","volume":"14","author":"Assad-Kottner","year":"2008","journal-title":"J. Card. Fail."},{"issue":"9","key":"10.1016\/j.ijcard.2020.04.055_bb0065","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jchf.2018.03.019","article-title":"Ambulatory inotrope infusions in advanced heart failure: a systematic review and meta-analysis","volume":"6","author":"Nizamic","year":"2018","journal-title":"JACC Heart Fail."},{"issue":"7","key":"10.1016\/j.ijcard.2020.04.055_bb0070","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1253\/circj.CJ-12-0033","article-title":"Low-dose beta-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure","volume":"76","author":"Kobayashi","year":"2012","journal-title":"Circ. J."},{"issue":"3","key":"10.1016\/j.ijcard.2020.04.055_bb0075","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1067\/mhj.2001.117605","article-title":"Carvedilol titration in patients with congestive heart failure receiving inotropic therapy","volume":"142","author":"Kumar","year":"2001","journal-title":"Am. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2020.04.055_bb0080","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/CIRCHEARTFAILURE.114.001778","article-title":"Clinical characteristics and outcomes of intravenous inotropic therapy in advanced heart failure","volume":"8","author":"Hashim","year":"2015","journal-title":"Circ. Heart Fail."},{"issue":"4","key":"10.1016\/j.ijcard.2020.04.055_bb0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.amjmed.2014.01.001","article-title":"PICC-associated bloodstream infections: prevalence, patterns, and predictors","volume":"127","author":"Chopra","year":"2014","journal-title":"Am. J. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319349022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319349022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:48:05Z","timestamp":1759092485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527319349022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":17,"alternative-id":["S0167527319349022"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.04.055","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term milrinone therapy as a bridge to heart transplantation: Safety, efficacy, and predictors of failure","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.04.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}